Nanofiber-Hydrogel Composites for Soft Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current materials for soft tissue reconstruction, such as hydrogels and nanofibers, face challenges in maintaining mechanical integrity while allowing host tissue cells to penetrate and grow, leading to issues like fibrosis, encapsulation, and limited volume retention.
Innovation Solution
A composite material comprising functionalized hyaluronic acid networks covalently linked to polycaprolactone fibers, forming microbeads with controlled size and crosslinking, which are stable and promote tissue ingrowth.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If higher crosslinking densities are used to achieve sufficient mechanical property, then mechanical strength is improved, but host tissue cells are not able to penetrate and grow into the scaffolds
Solution Approach 1:
The patent applies parameter changes by systematically optimizing crosslinking density, pore size, and hydrogel composition to achieve the desired balance between mechanical strength and cell penetrability. Specifically, the crosslinking density is controlled within a range that provides sufficient structural support while maintaining pore sizes that allow cell infiltration, rather than using maximally crosslinked structures.
Solution Approach 2:
The patent employs composite materials by combining hydrogel matrices with nanofiber reinforcements. This composite structure provides the mechanical strength needed for structural integrity while the nanofibers create pathways that facilitate cell penetration and growth, resolving the contradiction between strength and cell accessibility.
2Ease of operation
If degradable hydrogels are used to allow cell ingrowth, then cell penetration is improved, but scarring and fibrous tissue formation occur because ingrowth occurs too slowly
Solution Approach 1:
The patent controls the degradation rate of the hydrogel by adjusting crosslinking density and composition parameters. This ensures that the hydrogel degrades at a rate matched to tissue regeneration, preventing both premature collapse and excessive slow degradation that would cause fibrosis.
Solution Approach 2:
The patent incorporates porous structures with optimized pore sizes and interconnectivity that facilitate rapid cell infiltration and tissue ingrowth. The porous architecture allows cells to penetrate deeply into the scaffold, ensuring timely tissue replacement and preventing fibrous encapsulation.
3Volume of stationary object
If conventional hydrogel fillers are used for soft tissue reconstruction, then volume restoration is achieved, but moderate to severe inflammation occurs and full original volume is not retained over time
Solution Approach 1:
The patent uses composite materials combining hydrogel matrices with nanofiber reinforcements and bioactive molecules. This composite structure provides sustained volume restoration while the nanofibers and bioactive components reduce inflammation and improve tissue integration, preventing the fibrous encapsulation and volume loss seen with conventional fillers.
Solution Approach 2:
The patent introduces nanofibers and bioactive molecules as intermediaries between the hydrogel filler and host tissue. These intermediaries modulate the immune response, reduce inflammation, and promote tissue integration, thereby maintaining volume over time without the harmful effects of conventional fillers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite material supports tissue regeneration by maintaining mechanical integrity, reducing inflammation, and enabling host cell infiltration, thus providing long-lasting volume restoration.
Implementation Method 1
functionalized hyaluronic acid networks covalently linked to polycaprolactone fibers
Implementation Method 2
a crosslinking agent present at a concentration from about 1 mg/mL to about 25 mg/mL
Implementation Method 3
FDA-compliant synthetic biodegradable poly-α-esters, such as polycaprolactone (PCL) or poly(lactide-co-glycolide) (PLGA) can be used to generate nanofibers through a process known as electrospinning
Implementation Method 4
Hydrogels have received significant interest as ECM mimics due to their high water content and water-swollen networks
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
A composite material can include a gel and at least one nanostructure disposed within the gel. A method for healing a soft tissue defect can include applying a composite material to a soft tissue defect, wherein the composite material includes a gel and a nanostructure disposed within the gel. A method for manufacturing a composite material for use in healing soft tissue defects can include providing a gel and disposing nanofibers within the gel.